Dental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Dental pulp stem cells (DSCs) yield a secretome rich in bioactive molecules with therapeutic potential.
• Current research highlights in vitro and in vivo efficacy, yet clinical translation is limited by incomplete understanding of paracrine effects.
• Human dental pulp stem cells (hDPSCs) and stem cells from human exfoliated deciduous teeth (SHEDs) are key sources for these secretomes.

Purpose of the Study:

• To review current data on hDPSC- and SHED-derived secretomes for tissue regeneration.
• To explore the potential of these secretomes in bone, cartilage, and nerve tissue repair.
• To elucidate the paracrine mechanisms underlying the therapeutic effects of dental stem cell secretomes.

Main Methods:

• Literature review of published reports on dental stem cell secretomes.
• Analysis of studies investigating the effects of secretomes on neuroprotection, inflammation, apoptosis, and angiogenesis.
• Comparison of dental MSC-secretomes with bone marrow MSC-secretomes in cell-free therapy.

Main Results:

• Dental MSC-derived secretomes demonstrate efficacy in treating neurodegenerative diseases, neural injuries, cartilage defects, and bone repair.
• Therapeutic effects are mediated through neuroprotective, anti-inflammatory, antiapoptotic, and angiogenic paracrine mechanisms.
• Dental MSC-secretomes activate molecular and cellular pathways similar to bone marrow MSC-secretomes, supporting cell-free therapy.

Conclusions:

• Dental MSC-derived secretomes hold significant potential for tissue-regenerating therapies.
• The multidirectional paracrine effects of these secretomes are crucial for repairing diverse injured tissues.
• Further research into the precise paracrine mechanisms will facilitate clinical implementation of these cell-free therapies.